NCT05970913Active, not recruiting
PET-CT Predicting Lymph Nodes Metastasis
The Value of PET-CT in Predicting Lymph Nodes Metastasis in Non Small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
This study is a single-center prospective clinical study that aims to evaluate the predictive value of preoperative 18F-FDG-PET-CT and 18F-FAPI-PET/CT for lymph node metastasis in patients with non-small cell lung cancer. The final pathological results were used to assess the predictive value of PET-CT for lymph node metastasis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 280 (estimated)
- First submitted
- 23 Jul 2023
- Start date
- Nov 2023
- Primary completion date
- Mar 2026
- Lead sponsor
- Fudan University
- Diseases
- Lung cancer
- NCT number
- NCT05970913
What you commit to
- Study type: Observational
- Planned participants: 280
- From Nov 2023 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pleural dissemination observed during surgery.
- Received neoadjuvant therapy.
Other illness
- History of malignant tumors.
- Histopathological examination reveals lung malignancies other than non-small cell lung cancer (NSCLC).
Other
- Locally advanced or distant metastasis.
Who the study is looking for
- Solitary tumor, or multiple tumors with only ground-glass nodules (GGNs) apart from the primary lesion.
- Diameter of the primary lesion ≤5cm, with a CTR between 0.5 and 1.
- Pathological confirmation of non-small cell lung cancer (NSCLC) either before or during surgery.
- No prior radiotherapy or chemotherapy for initial treatment.
- No history of malignant tumors.
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.